Skip to Content

Xolair 300 mg solution for injection in pre-filled pen

Licence status
Authorised: 06/11/2023
Active substances
Omalizumab
Dosage Form
Solution for injection in pre-filled pen
Licence number
EU/1/05/319/015-017
Licence holder
Novartis Europharm Limited

Licence information

ATC code
R03DX05 omalizumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
06/11/2023